Skip to content

Public FDA record

Z-1458-2020: Nextra Hammertoe Correction System-4.5MM Middle, 3.2MM Proximal, SS, Sterile. REF: NX-4532K - Product Usa

Recall record Z-1458-2020 for Nextremity Solutions. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1458-2020
Company in FDA record
Nextremity Solutions
FDA classification date
Feb 24, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Proximal end of the driver in the affected product may be oversized in varying degrees, potentially making it difficult to connect with and remove from the proximal Nextra implant

Source facts

Action
Nextremity notified European distributors and customers of the FSCA via a Field Safety Notice dated 2/12/2020.The Field Safety Notice instructed return of all product with the specified lot number.
Initiated
2020-02-12
Root cause
Under Investigation by firm
Terminated
2020-12-17
Distribution
International distribution in the countries of Spain, United Kingdom, Germany, and Switzerland.
Recall number
Z-1458-2020
Recall status
Terminated
CDRH record ID
179667
FDA classified
2020-02-24
Recall event number
84924

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗